Manchester Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43K | Buy |
16
+15
| +1,500% | +$2.28K | ﹤0.01% | 982 |
|
|
2025
Q1 | $151 | Sell |
1
-95
| -99% | -$14.3K | ﹤0.01% | 1148 |
|
|
2024
Q4 | $17.7K | Buy |
96
+22
| +30% | +$4.06K | ﹤0.01% | 722 |
|
|
2024
Q3 | $14.6K | Buy |
74
+50
| +208% | +$9.85K | ﹤0.01% | 735 |
|
|
2024
Q2 | $4.96K | Buy |
+24
| New | +$4.96K | ﹤0.01% | 846 |
|
|
2021
Q3 | – | Sell |
-45
| Closed | -$17K | – | 1047 |
|
|
2021
Q2 | $17K | Buy |
+45
| New | +$17K | ﹤0.01% | 452 |
|
|
2021
Q1 | – | Sell |
-3
| Closed | -$1K | – | 671 |
|
|
2020
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 640 |
|